Entrepreneur Scientist Re-Appointed as Chairman of Medicines Discovery Catapult

Medicines Discovery Catapult (MDC) today announces the reappointment of experienced scientist and investor Dr Robin Brown, as Chairman.

Medicines Discovery Catapult and We Share Ventures collaborate in novel funding partnership to drive medicines discovery in areas of unmet patient need

Medicines Discovery Catapult (MDC) and We Share Ventures have embarked on a joint venture, piloting an innovative funding model aimed at opening new funding opportunities for early-stage medicines discovery.

Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester

The facility, which was closed in 2020, includes the multi-million pound cyclotron, one of only a handful in the UK.

New report reveals strength of the UK’s thriving genomics sector

The BioIndustry Association (BIA), the Wellcome Sanger Institute and Medicines Discovery Catapult (MDC) have today launched Genomics Nation.

Catapult Network welcomes Government’s Innovation Strategy and ambition to cement UK position as a world-leader in science, research and innovation

The Catapult Network is ready to play a key role in implementing the strategy and supporting industrial sectors to innovate.

Catapult Network Confirms Commitment to Equality, Diversity and Inclusion

The CEOs of all nine Catapults came together at a special event held in the High Value Manufacturing Catapult’s MTC in Coventry to sign the shared Inclusivity in Innovation Charter.

No code, no problem: Chief.AI and Medicines Discovery Catapult harness the power of AI for new pay as you go drug discovery platform

Chief.AI, in partnership with Medicines Discovery Catapult (MDC), has launched the first no-code, pay as you go, AI platform for drug discovery.

Medicines Discovery Catapult welcomes new scientific and people leaders

Medicines Discovery Catapult (MDC) is proud to announce an extension to its talented workforce.

MDC Seeks Buyer for Alderley Park Lighthouse Laboratory